Handheld imaging to track stem cells in knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new handheld imaging device (MPI) to track stem cells injected into the knee. It aims to see if the device can safely monitor how the stem cells move and work in people with knee osteoarthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with knee osteoarthritis by a doctor.
- You must be between 18 and 75 years old.
- Your knee osteoarthritis should be at a moderate stage (grade II or III on X-ray).
- You must have chronic knee pain from arthritis.
- You cannot have an active infection, such as HIV, hepatitis B, hepatitis C, or syphilis.
- You cannot have had a knee injection (like steroids) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an injection of stem cells (special cells that can help repair tissue) works better than a standard hyaluronic acid injection for knee osteoarthritis pain. Both treatments are injected into the knee to reduce pain and improve function.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This study tests a potential new treatment for knee osteoarthritis using stem cells from umbilical cord tissue. The therapy is injected into the knee to see if it can reduce pain and improve function, and it's being compared to a placebo.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
Hear when a new Knee Arthritis Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.